These results indicate that CD8+ T cells from GCB-LMP1/2A mice exhibit more potent proliferative and cytotoxic responses to T-ALL tumor cell lines, likely due to prior activation by BLMP1/2A cells in vivo, enhancing their antitumor immune function. The gene discussed is CD8A; the disease is acute lymphoblastic leukemia.